Phage therapy and antibiotics for joint infections
Part of Infections clinical trials.
This study tests whether adding a treatment with special viruses (called phages) to standard antibiotic care can help clear a joint infection more effectively after surgery. The goal is to improve your chances of keeping the artificial hip or knee and avoid the need for more procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your infection is in your hip or knee joint.
- The infection is caused by a single type of bacteria (Staphylococcus aureus or Pseudomonas aeruginosa) confirmed by a joint fluid test.
- You are scheduled for a surgery called DAIR, which cleans out the infected joint without removing the implant.
- Your health is stable and you are able to move around independently.
- You are not taking immune-suppressing medications (like for cancer or autoimmune diseases) or high-dose steroids, and you do not have an active viral infection like HIV (with low CD4 count).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a treatment using viruses that attack bacteria (called phages) to fight a stubborn joint infection that hasn't improved with other treatments. It may help people with chronic infections that resist antibiotics.
This trial tests a new treatment using viruses that attack bacteria (called phages) to fight infections in knee or hip replacements caused by Staphylococcus aureus. It may help people who still have the infection after a surgery to clean the joint, called DAIR.
This trial tests a treatment using viruses that attack bacteria to fight a chronic infection in a joint replacement. It might help people whose joint infection has not cleared up with standard antibiotics or surgery.
This trial tests a special treatment using viruses (called phages) that target and kill the bacteria causing a long-term joint replacement infection. It's designed for people who have tried many other treatments without success.
This study compares two antibiotic plans for acute (early) infections around an artificial knee or hip, using a procedure to clean the joint and try to keep the implant. It may help find the best approach to control infection and then prevent it from coming back with longer-term antibiotic treatment.
This trial tests a new medicine called PLG0206 to help prevent a knee infection from coming back after a procedure to clean the joint while keeping the artificial knee in place. If you qualify, you'll receive the study medicine or a placebo along with standard antibiotics.
Hear when a new Periprosthetic Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.